Blog Archives
18F-florbetaben Aβ imaging in mild cognitive impairment
Ong, Kevin; Villemagne, Victor L; Bahar-Fuchs, Alex; Lamb, Fiona; Chételat, Gaël; Raniga, Parnesh; Mulligan, Rachel S; Salvado, Olivier; Putz, Barbara; Roth, Katrin; Masters, Colin L; Reininger, Cornelia B; Rowe, Christopher C
3T sodium-MRI as predictor of neurocognition in nondemented older adults: a cross sectional study
Lui, Elaine; Venkatraman, Vijay K; Finch, Sue; Chua, Michelle; Li, Tie-Qiang; Sutton, Bradley P; Steward, Christopher E; Moffat, Bradford; Cyarto, Elizabeth V; Ellis, Kathryn A; Rowe, Christopher C; Masters, Colin L; Lautenschlager, Nicola T; Desmond, Patricia M
Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer’s disease
Lian, Yan; Jia, Yu-Juan; Wong, Joelyn; Zhou, Xin-Fu; Song, Weihong; Guo, Junhong; Masters, Colin L.; Wang, Yan-Jiang
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer’s disease pathophysiology (SNAP) or Alzheimer’s disease pathology: a longitudinal study
Burnham, Samantha C; Bourgeat, Pierrick; Doré, Vincent; Savage, Greg; Brown, Belinda; Laws, Simon; Maruff, Paul; Salvado, Olivier; Ames, David; Martins, Ralph N; Masters, Colin L; Rowe, Christopher C; Villemagne, Victor L
Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group
Dubois, Bruno; Villain, Nicolas; Frisoni, Giovanni B; Rabinovici, Gil D; Sabbagh, Marwan; Cappa, Stefano; Bejanin, Alexandre; Bombois, Stéphanie; Epelbaum, Stéphane; Teichmann, Marc; Habert, Marie-Odile; Nordberg, Agneta; Blennow, Kaj; Galasko, Douglas; Stern, Yaakov; Rowe, Christopher C; Salloway, Stephen; Schneider, Lon S; Cummings, Jeffrey L; Feldman, Howard H
Cognition and beta-amyloid in preclinical Alzheimer’s disease: Data from the AIBL study
Pike, Kerryn E.; Ellis, Kathryn A.; Villemagne, Victor L.; Good, Norm; Chételat, Gael; Ames, David; Szoeke, Cassandra; Laws, Simon M.; Verdile, Giuseppe; Martins, Ralph N.; Masters, Colin L.; Rowe, Christopher C.
Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer’s disease.
Lim, Yen Ying; Ellis, Kathryn A.; Harrington, Karra; Kamer, Adrian; Pietrzak, Robert H.; Bush, Ashley I.; Darby, David; Martins, Ralph N.; Masters, Colin L.; Rowe, Christopher C.; Savage, Greg; Szoeke, Cassandra; Villemagne, Victor L.; Ames, David; Maruff, Paul; The AIBL Research Group
Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD
Papp, Kathryn V.; Buckley, Rachel; Mormino, Elizabeth; Maruff, Paul; Villemagne, Victor L.; Masters, Colin L.; Johnson, Keith A.; Rentz, Dorene M.; Sperling, Reisa A.; Amariglio, Rebecca E.; on behalf of Collaborators from the Harvard Aging Brain Study, the Alzheimer's Disease Neuroimaging Initiative and the Australian Imaging, Biomarker and Lifestyle Study of Aging
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer’s disease: An international overview
Delaby, Constance; Teunissen, Charlotte E.; Blennow, Kaj; Alcolea, Daniel; Arisi, Ivan; Amar, Elodie Bouaziz; Beaume, Anne; Bedel, Aurélie; Bellomo, Giovanni; Bigot‐Corbel, Edith; Bjerke, Maria; Blanc‐Quintin, Marie‐Céline; Boada, Mercè; Bousiges, Olivier; Chapman, Miles D; DeMarco, Mari L.; D'Onofrio, Mara; Dumurgier, Julien; Dufour‐Rainfray, Diane; Engelborghs, Sebastiaan; Esselmann, Hermann; Fogli, Anne; Gabelle, Audrey; Galloni, Elisabetta; Gondolf, Clémentine; Grandhomme, […]
Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn
Lothian, Amber; Lago, Larissa; Mukherjee, Soumya; Connor, Andrea R.; Fowler, Chris; McLean, Catriona A.; Horne, Malcolm; Masters, Colin L.; Cappai, Roberto; Roberts, Blaine R.